Trial Profile
Phase II study on imatinib in combination with RAD001 in advanced chordoma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Sep 2018
Price :
$35
*
At a glance
- Drugs Everolimus (Primary) ; Imatinib (Primary)
- Indications Chordoma
- Focus Therapeutic Use
- 14 Sep 2018 Results published in the Cancer Journal.
- 12 Sep 2017 Status changed from recruiting to completed, according to results presented at the 42nd European Society for Medical Oncology Congress.
- 12 Sep 2017 Results presented at the 42nd European Society for Medical Oncology Congress.